封面
市场调查报告书
商品编码
1790973

经肠支架市场:各分类市场规模,占有率,法规,偿付,干预,2036年前的预测

Enteral Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

出版日期: | 出版商: GlobalData | 英文 | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

本研究报告提供一般外科器械治疗领域的定量和定性市场趋势,涵盖肠内支架市场规模、占有率、监管、报销、干预措施及2036年各细分市场预测。

肠内支架是一种穿孔的可扩张管,插入体内通道,以缓解某些疾病引起的血流受限。肠内支架主要用于维持胃肠道通畅。肠内支架是一种安宁疗护手段,用于有胃肠道阻塞风险的患者。

肠内支架是一种安宁疗护手段,用于有胃肠道阻塞风险的病人。这些患者通常面临食道癌、胰臟癌、胃癌或结肠癌的风险,这些肿瘤会直接侵袭胃肠道或造成危险的压迫。肠内支架可以保持胃肠道管腔畅通,显着改善患者的生活品质。

本研究为39个国家提供了颜色编码、来源齐全的市场模型,其中包含基于流行病学的适应症和干预量。提供的互动式Excel文件涵盖了价值、数量、产品用途、平均销售价格、市场规模以及公司占有率/排名分析(如有)。此外,基于定性分析的分析师评论为定量数据提供了背景。

市场模型的关键内容

目前的肠内支架市场及不断变化的竞争格局

  • 深入分析关键产业趋势
  • 2015-2036年肠内支架市场各细分市场年度总销售额及市场展望
  • 各细分市场总手术量、单位数量、平均售价及市场价值的详细数据

全球、区域与国家级市场洞察

  • 探索定性、特定市场讯息,并进一步按区域细分,了解全球趋势。此外,GlobalData分析师也提供独特的特定国家市场洞察。
  • 肠内支架市场的 SWOT 分析
  • 肠内支架市场的竞争态势与趋势

获得真正全面的视角,包括对医疗保健体系的概述,有助于理解市场。市场区隔也能让我们更深入了解市场动态,包括报销政策和监管环境资讯。

  • 各国医疗保健体系概览
  • 各国报销政策
  • 各国医疗科技监理现状

凭藉我们强大的方法论和资料来源,我们提供全面且准确的市场概览。主要的供需资讯被整合到一个包含关键产业专家的联合模型中。此外,我们也利用真实资料来源,例如政府流程资料库、医院采购资料库和专有线上资料库,来了解市场趋势。

目标公司:波士顿科学公司、威尔森库克医疗公司、Merit Medical Systems Inc、南京微技术有限公司、泰熊医疗有限公司、MITech有限公司等

目标国家:美国、英国、德国、法国、义大利、西班牙、巴西、中国、印度、俄罗斯、日本、澳洲、加拿大、墨西哥、韩国、丹麦、爱尔兰、荷兰、纽西兰、南非、瑞典、瑞士、奥地利、比利时、芬兰、以色列、挪威、波兰、葡萄牙、台湾、捷克共和国、希腊、匈牙利、土耳其、埃及、沙乌地阿拉伯、阿联酋、阿根廷和智利

范围

此市场模型提供了其他来源无法获得的关键专业见解。该模型展示了特定市场内的定性和定量趋势。以下人士是此模型的必读对象:

  • 需要深入了解肠内支架市场,以便为策略和投资决策提供资讯的CMO高阶主管。
  • 需要了解供应基础关键组成部分,以便做出供应商选择和管理决策的采购主管。
  • 需要深入了解市场,以识别和评估潜在投资目标的私募股权投资者。

购买理由

使用此模型,您可以:

  • 识别关键参与者,并透过审查其产品线,制定和设计许可引进和许可外销策略。
  • 透过了解塑造和推动肠内支架市场的趋势来制定商业策略。
  • 透过了解关键趋势、创新产品和技术、细分市场以及可能影响肠内支架市场的公司,来推动企业收入。
  • 透过了解竞争格局和分析市场领导者的市场占有率,来制定有效的销售和行销策略。
  • 识别具有潜在强大产品组合的新兴进入者,并制定有效的应对策略以获得竞争优势。
  • 追踪2015年至2036年全球及各国肠内支架市场的设备销售情形。
  • 透过识别最有可能实现整合、投资和策略合作的市场类别和细分市场,组织您的销售和行销工作。
简介目录
Product Code: GDME596MM

Enteral Stents Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.

An Enteral Stent is a perforated expandable tube which is inserted into a passage of the body in order to alleviate the constriction of flow caused by any disease. Enteral stents are primarily used to maintain patency of the lumen of the gastrointestinal tract. Enteral stents are a palliative measure, used in patients who are at risk of suffering from a blocked gastrointestinal passage.

Enteral stents are a palliative measure, used in patients who are at risk of suffering from a blocked gastrointestinal passage. Those who are at risk are usually suffering from esophogeal, pancreatic, gastric, or colorectal cancer and have tumors that either directly invade the gastrointestinal tract, or cause dangerous compression. Enteral stents can allow the gastrointestinal lumen to stay open, which can drastically improve the quality of life for the patient.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with Intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Enteral Stents and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Enteral Stents market revenue by segment and market outlooks from 2015-2036.
  • Granular data on total Interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Enteral Stents market.
  • Competitive dynamics insights and trends provided for Enteral Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Wilson-Cook Medical Inc, Merit Medical Systems Inc, Micro-Tech Nanjing Co Ltd, Taewoong Medical Co Ltd, MITech Co Ltd, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Enteral Stents marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving Enteral Stents market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Enteral Stents market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Enteral Stents market from 2015-2036.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.